or Try an Advanced Search...

    Technical Analysis for BNTX - BioNTech SE

    Grade Last Price % Change Price Change
    D 96.95 -2.07% -2.05
    BNTX closed down 2.07 percent on Friday, May 24, 2024, on 1.81 times normal volume.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical BNTX trend table...
    Date Alert Name Type % Chg
    Upper Bollinger Band Walk Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Fell Below 200 DMA Bearish -2.07%
    Jack-in-the-Box Bullish Bullish Swing Setup -2.07%
    Upper Bollinger Band Walk Strength -2.07%
    Multiple of Ten Bearish Other -2.07%
    Inside Day Range Contraction -2.07%
    Above Upper BB Strength -2.07%
    Upper Bollinger Band Touch Strength -2.07%
    Crossed Above 200 DMA Bullish -5.23%
    Older End-of-Day Signals for BNTX ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown 3 days ago
    Down 3% 3 days ago
    Down 2 % 3 days ago
    Down 1 ATR 3 days ago
    2x Volume Pace 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    BNTX Chart by TradingView
    Basic chart:

    Profile

    BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Biomarkers Allergy Autoimmunity In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device

    Is BNTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 26 Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?
    May 24 Why Vaccine Stocks Rallied This Week
    May 24 Critical Insights From BioNTech Analyst Ratings: What You Need To Know
    May 23 New COVID FLiRT variants spike as FDA delays key vaccine meeting
    May 23 Chart Advisor: Bitcoin Surging toward Record Highs
    May 22 Moderna, BioNTech close with double-digit percentage gains amid bird flu fears
    May 22 COVID-19 vaccine makers rebound amid post-pandemic prospects
    May 21 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO Annual Meeting 2024
    May 18 Q1 2024 Autolus Therapeutics PLC Earnings Call
    May 17 European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
    See more BNTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 125.83
    52 Week Low 85.2129
    Average Volume 689,583
    200-Day Moving Average 99.52
    50-Day Moving Average 90.92
    20-Day Moving Average 92.67
    10-Day Moving Average 94.36
    Average True Range 3.09
    RSI (14) 59.02
    ADX 21.36
    +DI 31.56
    -DI 16.56
    Chandelier Exit (Long, 3 ATRs) 93.38
    Chandelier Exit (Short, 3 ATRs) 95.41
    Upper Bollinger Bands 99.19
    Lower Bollinger Band 86.15
    Percent B (%b) 0.83
    BandWidth 14.07
    MACD Line 1.91
    MACD Signal Line 1.15
    MACD Histogram 0.764
    Fundamentals Value
    Market Cap 23.05 Billion
    Num Shares 238 Million
    EPS 12.15
    Price-to-Earnings (P/E) Ratio 7.98
    Price-to-Sales 3.38
    Price-to-Book 1.03
    PEG Ratio 0.04
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 104.08
    Resistance 3 (R3) 104.06 101.66 102.89
    Resistance 2 (R2) 101.66 99.85 101.67 102.49
    Resistance 1 (R1) 99.31 98.73 98.11 99.33 102.10
    Pivot Point 96.91 96.91 96.32 96.92 96.91
    Support 1 (S1) 94.56 95.10 93.36 94.58 91.80
    Support 2 (S2) 92.16 93.98 92.17 91.41
    Support 3 (S3) 89.81 92.16 91.01
    Support 4 (S4) 89.83